| Identification | Back Directory | [Name]
(3alpha,5beta,7alpha,12alpha)-3,7,12-Tris(formyloxy)cholan-24-oic acid | [CAS]
2097-89-4 | [Synonyms]
Tri-O-formylcholic Acid
OHJFKWAMNYLNEV-OCCHXLOTSA-N
3a,7a,12a-tri(forMyloxy)-5b-cholanic acid
3α,7α,12α-tri(formyloxy)-5β-cholan-24-oic acid
3α,7α,12α-tri(forMyloxy)-5β-cholan-24-oic acid
(3α,5β,7α,12α)-3,7,12-Tris(forMyloxy)cholan-24-oic acid
Cholan-24-oic acid, 3,7,12-tris(formyloxy)-, (3α,5β,7α,12α)-
(3alpha,5beta,7alpha,12alpha)-3,7,12-Tris(formyloxy)cholan-24-oic acid | [Molecular Formula]
C27H40O8 | [MDL Number]
MFCD26961051 | [MOL File]
2097-89-4.mol | [Molecular Weight]
492.6 |
| Hazard Information | Back Directory | [Uses]
Tri-O-formylcholic Acid is an intermediate used in the synthesis of 3α,7α,12α-Trihydroxycoprostanic Acid-d3 (T795157), which is a labelled analogue of 3α,7α,12α-Trihydroxycoprostanic Acid (T795155), a precursor of Cholic Acid (C432600), it undergoes side chain oxidation during the synthesis of bile acids. It was found that Zellweger’s syndrome patients have abnormal mitochondrial structure, the organelle that is responsible for the side chain oxidation, and as a consequence, excess amounts of 3α,7α,12α-Trihydroxycoprostanic Acid. |
|
|